A vaccine that targets the malaria parasite at a vulnerable point in its development could form part of a strategy to eradicate the disease.
An exclusive New Scientist survey reveals what precautions flu experts have been taking, and if they think a more virulent strain will emerge.
Forfeiting our commons
The Lancet’s Series on Maternal and Child Undernutrition
President Obama's grand climate plan does not add up
Climate change can no longer be ignored
NGO demands withdrawal of Niyamgiri gram sabha notificatio
